Compare · MEDP vs NRC
MEDP vs NRC
Side-by-side comparison of Medpace Holdings Inc. (MEDP) and NRC Health (NRC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MEDP and NRC operate in Biotechnology: Commercial Physical & Biological Resarch (Health Care), so they compete in similar markets.
- MEDP is the larger of the two at $6.09B, about 6.0x NRC ($1.01B).
- Over the past year, MEDP is up 37.6% and NRC is up 59.1% - NRC leads by 21.5 points.
- MEDP has been more active in the news (3 items in the past 4 weeks vs 2 for NRC).
- MEDP has more recent analyst coverage (25 ratings vs 0 for NRC).
- Company
- Medpace Holdings Inc.
- NRC Health
- Price
- $410.42+4.41%
- $17.18-0.66%
- Market cap
- $6.09B
- $1.01B
- 1M return
- -12.08%
- +0.73%
- 1Y return
- +37.65%
- +59.12%
- Industry
- Biotechnology: Commercial Physical & Biological Resarch
- Biotechnology: Commercial Physical & Biological Resarch
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2016
- News (4w)
- 3
- 2
- Recent ratings
- 25
- 0
Medpace Holdings Inc.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It also provides clinical development services to the biotechnology, pharmaceutical, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. The company also provides bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.
NRC Health
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs; and transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Latest MEDP
- SEC Form 10-Q filed by Medpace Holdings Inc.
- Medpace Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits
- Medpace Holdings, Inc. Reports First Quarter 2026 Results
- SEC Form 4 filed by Mccarthy Cornelius P. Iii
- SEC Form 4 filed by Kraft Robert O.
- SEC Form 4 filed by Carley Brian T
- SEC Form DEFA14A filed by Medpace Holdings Inc.
- SEC Form DEF 14A filed by Medpace Holdings Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Medpace Holdings Inc.
- Medpace Holdings, Inc. to Report First Quarter 2026 Financial Results on April 22, 2026
Latest NRC
- National Research Corporation filed SEC Form 8-K: Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- Ann & Robert H. Lurie Children's Hospital of Chicago Expands Partnership with NRC Health to Strengthen Consumer Insight and Online Reputation Strategy
- Amendment: SEC Form SCHEDULE 13D/A filed by National Research Corporation
- Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth
- Executive Vice President Rau Jason Russell was granted 60,000 shares (SEC Form 4)
- NRC Health Announces Board Authorization of $60 Million Share Repurchase Program
- SEC Form S-8 filed by National Research Corporation
- SEC Form 10-K filed by National Research Corporation
- NRC Health Provides Business Update
- EVP & Chief Financial Officer Harrison Shane R bought $98,162 worth of shares (8,000 units at $12.27) (SEC Form 4)